Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2017

Jul 28, 2017

32939_dirs_2017-07-28_e809c319-b6f9-43fa-9679-cc577d53377d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-07-25

Reporting Person: GOLD JEFFREY (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-25 Common Stock M 14000 $15.75 Acquired 66037 Direct
2017-07-25 Common Stock F 12879 $17.12 Disposed 53158 Direct
2017-07-26 Common Stock A 7976 Acquired 61134 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-07-25 Non-Qualified Stock Option (right to buy) $15.75 M 14000 Disposed 2017-08-03 Common Stock (14000) Direct

Footnotes

F1: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018.

F2: Options for 33 1/3% of the total number of shares each became exercisable on 8/3/2011, 8/3/2012 and 8/3/2013.